Tekla Healthcare Investors Stock Forecast, Price & News

Tekla Healthcare Investors (NYSE:HQH) Frequently Asked Questions

How has Tekla Healthcare Investors' stock been impacted by Coronavirus?

Tekla Healthcare Investors' stock was trading at $17.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, HQH shares have increased by 34.8% and is now trading at $24.08.
View which stocks have been most impacted by COVID-19.

Are investors shorting Tekla Healthcare Investors?

Tekla Healthcare Investors saw a drop in short interest in October. As of October 29th, there was short interest totaling 263,600 shares, a drop of 14.5% from the October 14th total of 308,200 shares. Based on an average daily volume of 119,100 shares, the days-to-cover ratio is currently 2.2 days.
View Tekla Healthcare Investors' Short Interest.

How often does Tekla Healthcare Investors pay dividends? What is the dividend yield for Tekla Healthcare Investors?

Tekla Healthcare Investors declared a quarterly dividend on Monday, November 15th. Stockholders of record on Wednesday, November 24th will be given a dividend of $0.51 per share on Friday, December 31st. This represents a $2.04 dividend on an annualized basis and a yield of 8.47%. The ex-dividend date is Tuesday, November 23rd.
View Tekla Healthcare Investors' dividend history.

Is Tekla Healthcare Investors a good dividend stock?

Tekla Healthcare Investors pays an annual dividend of $2.52 per share and currently has a dividend yield of 10.54%. HQH has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View Tekla Healthcare Investors' dividend history.

Who are Tekla Healthcare Investors' key executives?

Tekla Healthcare Investors' management team includes the following people:

• Dan Omstead, President & Trustee
• Laura F. Woodward, Secretary, Treasurer & Chief Compliance Officer

Who are some of Tekla Healthcare Investors' key competitors?

Some companies that are related to Tekla Healthcare Investors include SPDR Nuveen Barclays Municipal Bond ETF (TFI), DNP Select Income Fund (DNP), Direxion Daily Financial Bull 3X Shares (FAS), iShares MSCI Pacific ex Japan ETF (EPP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), Royce Value Trust (RVT), Goldman Sachs BDC (GSBD), Hercules Capital (HTGC), PIMCO Corporate & Income Opportunity Fund (PTY), Tri-Continental (TY), The Gabelli Equity Trust (GAB), Liberty All-Star Equity Fund (USA), WisdomTree Emerging Markets High Dividend Fund (DEM) and iShares MSCI Australia ETF (EWA).
View all of HQH's competitors.

What other stocks do shareholders of Tekla Healthcare Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tekla Healthcare Investors investors own include AT&T (T), Enterprise Products Partners (EPD), Main Street Capital (MAIN), Energy Transfer (ET), PIMCO Dynamic Credit and Mortgage Income Fund (PCI), Ares Capital (ARCC), Annaly Capital Management (NLY), Gilead Sciences (GILD), Iron Mountain (IRM) and AbbVie (ABBV).

What is Tekla Healthcare Investors' stock symbol?

Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."

Who are Tekla Healthcare Investors' major shareholders?

Tekla Healthcare Investors' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Morgan Stanley (7.21%), Royal Bank of Canada (1.19%), Raymond James Financial Services Advisors Inc. (0.72%), LPL Financial LLC (0.71%), UBS Group AG (0.69%) and Raymond James & Associates (0.59%).
View institutional ownership trends for Tekla Healthcare Investors.

Which institutional investors are selling Tekla Healthcare Investors stock?

HQH stock was sold by a variety of institutional investors in the last quarter, including Cetera Investment Advisers, Royal Bank of Canada, Raymond James & Associates, Oppenheimer & Co. Inc., Laidlaw Wealth Management LLC, Stephens Inc. AR, B. Riley Wealth Management Inc., and HighTower Advisors LLC.
View insider buying and selling activity for Tekla Healthcare Investors or view top insider-selling stocks.

Which institutional investors are buying Tekla Healthcare Investors stock?

HQH stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, U.S. Capital Wealth Advisors LLC, Private Advisor Group LLC, LPL Financial LLC, Cetera Advisor Networks LLC, UBS Group AG, Rockefeller Capital Management L.P., and StoneX Group Inc..
View insider buying and selling activity for Tekla Healthcare Investors or or view top insider-buying stocks.

How do I buy shares of Tekla Healthcare Investors?

Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tekla Healthcare Investors' stock price today?

One share of HQH stock can currently be purchased for approximately $24.08.

How much money does Tekla Healthcare Investors make?

Tekla Healthcare Investors has a market capitalization of $1.08 billion.

How many employees does Tekla Healthcare Investors have?

Tekla Healthcare Investors employs 147,000 workers across the globe.

What is Tekla Healthcare Investors' official website?

The official website for Tekla Healthcare Investors is www.teklacap.com.

Where are Tekla Healthcare Investors' headquarters?

Tekla Healthcare Investors is headquartered at 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109.

How can I contact Tekla Healthcare Investors?

Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at (617) 772-8500, via email at [email protected], or via fax at 617-772-8577.